An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C

K. Patel, Y. Benhamou, E. M. Yoshida, K. D. Kaita, S. Zeuzem, M. Torbenson, E. Pulkstenis, G. M. Subramanian, J. G. McHutchison

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C'. Together they form a unique fingerprint.

Medicine & Life Sciences